Filter
1720
Text search:
health
commodities
Featured
138
645
Language
Document type
1017
288
166
115
67
24
19
15
6
1
Countries / Regions
108
80
75
69
60
56
55
54
47
46
46
45
39
37
30
24
24
23
22
22
21
21
19
15
14
14
13
12
12
11
11
11
11
11
11
10
9
9
8
8
8
8
7
7
6
6
6
5
5
5
5
4
4
4
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
951
111
103
80
65
19
15
Toolboxes
129
124
61
59
53
50
45
42
42
37
33
28
23
22
19
15
11
10
9
7
6
6
5
3
2
1
1
Accessed March 14, 2017
TB in India 2017
recommended
Revised National TB Control Programme. Annual Status Report
4th edition
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
...
Managing possible serious bacterial infection in young infants when referral is not feasible
recommended
It provides guidance on care for use in resource-limited settings or in settings where families with sick young infants do not accept or cannot access referral care, but can be managed in outpatient settings by an appropriately trained health worker
...
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and
...
